Ajinomoto Co. Inc. (TYO:2802) is positioning cutting-edge operations as a driver of future business growth for its contract manufacturing of…...
Please subscribe to read the full story.
antibodies
PeptiDream, Nihon Medi-Physics Plan Joint R&D for Simultaneous Diagnosis and Treatment of Cancer
PeptiDream Inc. (TYO:4587) and Nihon Medi-Physics Co. Ltd. (NMP) announced on Dec. 18 that they intend to conduct joint efforts…...
Please subscribe to read the full story.
Siam Bioscience Readies to Commercialize Monoclonal Antibodies
Thai biopharmaceuticals firm Siam Bioscience Co. Ltd. is planning to begin commercial business operations for monoclonal antibodies in 2019. As…...
Please subscribe to read the full story.
